<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="modify">
            <roleset id="modify.01" name="" wordnet="3">
                <roles>
                    <role n="0" descr="agent, cause of transformation&#x0A;" />
                    <role n="1" descr="thing changing&#x0A;" />
                    <role n="2" descr="method&#x0A;" />
                    <role n="3" descr="consequence&#x09;&#x09;&#x09;&#x09;// secondary predication //&#x0A;" />
                </roles>
                <example src="PERMUTATE" no="0">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which being apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which being modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which are able to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which are observed to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which can be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which can be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which have been apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which have been modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which have the ability to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which may be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which may be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which might have been apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which might have been modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which were apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which were modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which will be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which will be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, subunits are apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are able to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are observed to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III can be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III can be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III have been apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III have been modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III have the ability to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III may be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III may be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III might have been apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III might have been modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III were apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III were modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III will be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III will be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes being apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes being modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which are able to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which are observed to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which can be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which can be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which have been apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which have been modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which have the ability to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which may be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which may be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which might have been apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which might have been modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which were apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which were modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which will be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which will be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, subunits are apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum being apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum being modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which are able to be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which are observed to be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which can be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which can be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which have been apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which have been modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which have the ability to be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which may be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which may be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which might have been apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which might have been modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which were apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which were modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which will be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which will be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, subunits are apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are able to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are observed to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III can be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III can be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III have been apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III have been modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III have the ability to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III may be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III may be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III might have been apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III might have been modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III were apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III were modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III will be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III will be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III are able to be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III are apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III are modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III are observed to be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III can be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III can be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III have been apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III have been modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III have the ability to be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III may be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III may be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III might have been apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III might have been modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III were apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III were modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III will be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III will be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
